175 related articles for article (PubMed ID: 22529899)
1. Biodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenografts.
Li J; Gong C; Feng X; Zhou X; Xu X; Xie L; Wang R; Zhang D; Wang H; Deng P; Zhou M; Ji N; Zhou Y; Wang Y; Wang Z; Liao G; Geng N; Chu L; Qian Z; Wang Z; Chen Q
PLoS One; 2012; 7(4):e33860. PubMed ID: 22529899
[TBL] [Abstract][Full Text] [Related]
2. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anticancer efficacy of histone deacetyl inhibitor, suberoylanilide hydroxamic acid, in combination with a phosphodiesterase inhibitor, pentoxifylline, in human cancer cell lines and in-vivo tumor xenografts.
Nidhyanandan S; Thippeswamy BS; Chandrasekhar KB; Reddy ND; Kulkarni NM; Karthikeyan K; Khan FR; Raghul J; Vijaykanth G; Narayanan S
Anticancer Drugs; 2017 Oct; 28(9):1002-1017. PubMed ID: 28727579
[TBL] [Abstract][Full Text] [Related]
4. Prevention of corneal neovascularization by subconjunctival injection of avastin® loaded thermosensitive hydrogels in rabbit model.
Xu X; Yu J; Shi H; Zhang J; Li X
Int J Pharm; 2018 Dec; 552(1-2):164-170. PubMed ID: 30217769
[TBL] [Abstract][Full Text] [Related]
5. Thermosensitive hydrogel used in dual drug delivery system with paclitaxel-loaded micelles for in situ treatment of lung cancer.
Wu Z; Zou X; Yang L; Lin S; Fan J; Yang B; Sun X; Wan Q; Chen Y; Fu S
Colloids Surf B Biointerfaces; 2014 Oct; 122():90-98. PubMed ID: 25033428
[TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
[TBL] [Abstract][Full Text] [Related]
7. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
8. Thermosensitive PEG-PCL-PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium.
Luo Z; Jin L; Xu L; Zhang ZL; Yu J; Shi S; Li X; Chen H
Drug Deliv; 2016; 23(1):63-8. PubMed ID: 24758189
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo.
Yang B; Yu D; Liu J; Yang K; Wu G; Liu H
Tumour Biol; 2015 Jul; 36(7):5051-61. PubMed ID: 25649979
[TBL] [Abstract][Full Text] [Related]
10. Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma.
Chen X; Chen DR; Liu H; Yang L; Zhang Y; Bu LL; Sun ZJ; Cai L
J Control Release; 2022 Nov; 351():381-393. PubMed ID: 36096364
[TBL] [Abstract][Full Text] [Related]
11. Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.
Konstantinopoulos PA; Wilson AJ; Saskowski J; Wass E; Khabele D
Gynecol Oncol; 2014 Jun; 133(3):599-606. PubMed ID: 24631446
[TBL] [Abstract][Full Text] [Related]
12. Pendant HDAC inhibitor SAHA derivatised polymer as a novel prodrug micellar carrier for anticancer drugs.
Xu J; Sun J; Wang P; Ma X; Li S
J Drug Target; 2018; 26(5-6):448-457. PubMed ID: 29251528
[TBL] [Abstract][Full Text] [Related]
13. Growth-suppressive effect of suberoylanilide hydroxamic acid (SAHA) on human oral cancer cells.
Jang B; Shin JA; Kim YS; Kim JY; Yi HK; Park IS; Cho NP; Cho SD
Cell Oncol (Dordr); 2016 Feb; 39(1):79-87. PubMed ID: 26582320
[TBL] [Abstract][Full Text] [Related]
14. In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model.
Thiemann M; Oertel S; Ehemann V; Weichert W; Stenzinger A; Bischof M; Weber KJ; Perez RL; Haberkorn U; Kulozik AE; Debus J; Huber PE; Battmann C
Radiat Oncol; 2012 Mar; 7():52. PubMed ID: 22458853
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of suberoylanilide hydroxamic acid in esophageal squamous cancer cells in vitro and in vivo.
Tzao C; Jin JS; Chen BH; Chung HY; Chang CC; Hsu TY; Sun GH
Dis Esophagus; 2014; 27(7):693-702. PubMed ID: 24033428
[TBL] [Abstract][Full Text] [Related]
16. Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier.
Ma W; Sun J; Xu J; Luo Z; Diao D; Zhang Z; Oberly PJ; Minnigh MB; Xie W; Poloyac SM; Huang Y; Li S
Theranostics; 2020; 10(6):2463-2478. PubMed ID: 32194813
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo.
Nagumo T; Takaoka S; Yoshiba S; Ohashi M; Shirota T; Hatori M; Isobe T; Tachikawa T; Shintani S
Oral Oncol; 2009 Sep; 45(9):766-70. PubMed ID: 19157955
[TBL] [Abstract][Full Text] [Related]
18. Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cells.
Liang BY; Xiong M; Ji GB; Zhang EL; Zhang ZY; Dong KS; Chen XP; Huang ZY
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):535-540. PubMed ID: 26223923
[TBL] [Abstract][Full Text] [Related]
19. Acute toxicity evaluation of biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PEG-PCL-PEG hydrogel.
Gong CY; Wu QJ; Dong PW; Shi S; Fu SZ; Guo G; Hu HZ; Zhao X; Wei YQ; Qian ZY
J Biomed Mater Res B Appl Biomater; 2009 Oct; 91(1):26-36. PubMed ID: 19365823
[TBL] [Abstract][Full Text] [Related]
20. Thermosensitive PEG-PCL-PEG hydrogel controlled drug delivery system: sol-gel-sol transition and in vitro drug release study.
Gong CY; Dong PW; Shi S; Fu SZ; Yang JL; Guo G; Zhao X; Wei YQ; Qian ZY
J Pharm Sci; 2009 Oct; 98(10):3707-17. PubMed ID: 19189419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
